3DPrint.com October 11, 2024
Sarah Saunders

Last year, Baltimore-based medical device company Kallisio received FDA 510(k) clearance for its 3D printed patient-specific Stentra device. Oral stents like this are critically important in protecting a patient’s healthy tissue during radiation treatments for head and neck cancers (HNC). Now, the company has announced a strategic partnership with RICOH 3D for Healthcare to make and distribute Stentra to improve radiation oncology care.

“Partnering with RICOH 3D for Healthcare is a natural fit for our mission to transform cancer care. Ricoh’s expertise in advanced manufacturing and their robust distribution network, including point-of-care production capabilities and clinical applications team, make them an ideal partner,” said Kallisio CEO Rajan Patel. “Together, we can ensure that Stentra™ reaches radiation oncology teams efficiently,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: 3D Printing, Technology
Beyond DeepSeek: Reimagining AI Integration in China’s 3D Printing Industry
Advanced 3D Printed Medtech Solutions Transform Healthcare Treatments and Improve Patient Outcomes
The Importance of Services in 3D Printing: Steady Growth and Promising Potential
Game-Changing $115M for Aspect Biosystems’ Bioprinted Tech
3D Printing Predictions for 2025: Software

Share This Article